Crossmark

Case report: coeliac disease as a cause of secondary failure of glibenclamide therapy in a patient with permanent neonatal diabetes due to KCNJ11/R201C mutation

Crossref DOI link: https://doi.org/10.1007/s00125-021-05454-y

Published Online: 2021-05-14

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iafusco, Dario https://orcid.org/0000-0002-9398-3856
Zanfardino, Angela https://orcid.org/0000-0003-0641-1321
Piscopo, Alessia https://orcid.org/0000-0002-8754-2990
Casaburo, Francesca https://orcid.org/0000-0002-4135-3414
De Nigris, Angelica https://orcid.org/0000-0002-9594-2898
Alfiero, Salvatore https://orcid.org/0000-0003-4794-3711
Russo, Giuseppina https://orcid.org/0000-0002-5692-7337
Arenella, Mattia https://orcid.org/0000-0001-9847-7840
Russo, Maria Cecilia https://orcid.org/0000-0001-8415-4696
Barbetti, Fabrizio https://orcid.org/0000-0003-4687-980X
Funding

Funding for this research was provided by:

Università degli Studi della Campania Luigi Vanvitelli
License Information

Text and Data Mining valid from 2021-05-14

Version of Record valid from 2021-05-14
More Information

Article History

Received: 19 November 2020

Accepted: 8 January 2021

First Online: 14 May 2021